Patent Assignment
Reel/Frame 061312/0422
Assignment of Assignor's Interest
Recorded: 2022-08-24
Pages: 7
Assignors
WALKER, LUKE
Executed: 2020-10-28
RAMOS, JORGE
Executed: 2020-10-23
PARKER, AULMA
Executed: 2020-10-19
Assignee
SEAGEN INC.
21823 30TH DR. S.E., BOTHELL, WASHINGTON, 98021
Covered Property
(1)
Methods of Treating HER2 Positive Breast Cancer with Tucatinib in Combination with an Anti-HER2 Antibody-Drug Conjugate
Application:
17/775,492 →
Publication:
US 2022/0387618
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 24, 2022
From: WALKER, LUKE
To: SEATTLE GENETICS, INC.
Reel/Frame 060883/0679 →
Assignment of Assignor's Interest
Aug 24, 2022
From: WALKER, LUKE
To: SEATTLE GENETICS, INC.
Reel/Frame 060883/0760 →
Assignment of Assignor's Interest
Aug 24, 2022
From: RAMOS, JORGE; PARKER, AULMA
To: SEAGEN INC.
Reel/Frame 060884/0111 →
Assignment of Assignor's Interest
Aug 24, 2022
From: KULUKIAN, ANITA
To: SEAGEN INC.
Reel/Frame 060884/0724 →
Change of Name
Aug 24, 2022
From: SEATTLE GENETICS, INC.
To: SEAGEN INC.
Reel/Frame 061312/0361 →